Professor Sir Michael Rawlins believed side effects of medicine "was a judgment of balancing safety and efficacy." Read more about Professor Sir Michael Rawlins believed side effects of medicine "was a judgment of balancing safety and efficacy."
Professor Sir Michael Rawlins did not know why the CSM had not pressed for greater transparency at an earlier stage. Read more about Professor Sir Michael Rawlins did not know why the CSM had not pressed for greater transparency at an earlier stage.
The CSM(B) members would know the views of the Medicines Division staff, for their reports did not simply summarise any danger but expressed a view on it. Read more about The CSM(B) members would know the views of the Medicines Division staff, for their reports did not simply summarise any danger but expressed a view on it.
The Sub-Committee on Biological Products ("CSM(B)") worked on its own. Read more about The Sub-Committee on Biological Products ("CSM(B)") worked on its own.
The functions of the Secretaries of State for Health of the UK, as Licensing Authority, under the Medicines Act 1968, were discharged by the Medicines Division of the DHSS. Read more about The functions of the Secretaries of State for Health of the UK, as Licensing Authority, under the Medicines Act 1968, were discharged by the Medicines Division of the DHSS.
Dr Walford referred to "the cries from some quarters to ban the import of Factor VIII". It was not universally accepted at the time. Read more about Dr Walford referred to "the cries from some quarters to ban the import of Factor VIII". It was not universally accepted at the time.
The Haemophilia Society informed the DHSS that they wanted to discuss - among other subjects - the "no ban on the importation of American concentrates." Read more about The Haemophilia Society informed the DHSS that they wanted to discuss - among other subjects - the "no ban on the importation of American concentrates."
Professor Bloom argued publicly and very strongly for steps to be taken to reduce or eliminate the risk of HIV transmission, without arguing that there was yet no conclusive proof that heat treatment would necessarily be safe. Read more about Professor Bloom argued publicly and very strongly for steps to be taken to reduce or eliminate the risk of HIV transmission, without arguing that there was yet no conclusive proof that heat treatment would necessarily be safe.
At a Reference Centre Directors' meeting, Professor Bloom stated that it was "difficult to avoid the argument that non-HT [non-heat treated] constitutes a risk." Read more about At a Reference Centre Directors' meeting, Professor Bloom stated that it was "difficult to avoid the argument that non-HT [non-heat treated] constitutes a risk."
Minutes of a UKHCDO meeting recorded that Dr Malcolm Chisholm wondered if directors could revert to cryoprecipitate, given the "worry of patients" to which Professor Bloom responded that "he felt there was no need for patients to stop using the commercial concentrates because at present there was no proof that commercial concentrates were the cause of AIDS". Read more about Minutes of a UKHCDO meeting recorded that Dr Malcolm Chisholm wondered if directors could revert to cryoprecipitate, given the "worry of patients" to which Professor Bloom responded that "he felt there was no need for patients to stop using the commercial concentrates because at present there was no proof that commercial concentrates were the cause of AIDS".